nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—GABBR1—prostate gland—urinary bladder cancer	0.0356	0.13	CbGeAlD
Vigabatrin—GABBR1—seminal vesicle—urinary bladder cancer	0.0301	0.11	CbGeAlD
Vigabatrin—SLC36A1—prostate gland—urinary bladder cancer	0.028	0.102	CbGeAlD
Vigabatrin—ABAT—prostate gland—urinary bladder cancer	0.0278	0.102	CbGeAlD
Vigabatrin—GABBR1—urethra—urinary bladder cancer	0.0239	0.0874	CbGeAlD
Vigabatrin—SLC36A1—renal system—urinary bladder cancer	0.0191	0.0699	CbGeAlD
Vigabatrin—ABAT—renal system—urinary bladder cancer	0.019	0.0694	CbGeAlD
Vigabatrin—GABBR1—vagina—urinary bladder cancer	0.0176	0.0644	CbGeAlD
Vigabatrin—SLC36A1—female reproductive system—urinary bladder cancer	0.0153	0.0559	CbGeAlD
Vigabatrin—SLC36A1—vagina—urinary bladder cancer	0.0138	0.0506	CbGeAlD
Vigabatrin—ABAT—vagina—urinary bladder cancer	0.0137	0.0503	CbGeAlD
Vigabatrin—GABBR1—lymph node—urinary bladder cancer	0.0114	0.0417	CbGeAlD
Vigabatrin—SLC36A1—lymph node—urinary bladder cancer	0.00894	0.0327	CbGeAlD
Vigabatrin—ABAT—lymph node—urinary bladder cancer	0.00888	0.0325	CbGeAlD
Vigabatrin—Depression—Methotrexate—urinary bladder cancer	0.00073	0.001	CcSEcCtD
Vigabatrin—Pain—Cisplatin—urinary bladder cancer	0.000728	0.001	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000726	0.000999	CcSEcCtD
Vigabatrin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000722	0.000993	CcSEcCtD
Vigabatrin—Dizziness—Thiotepa—urinary bladder cancer	0.000718	0.000988	CcSEcCtD
Vigabatrin—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000716	0.000985	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000715	0.000983	CcSEcCtD
Vigabatrin—Urticaria—Fluorouracil—urinary bladder cancer	0.000713	0.000982	CcSEcCtD
Vigabatrin—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000712	0.00098	CcSEcCtD
Vigabatrin—Influenza—Doxorubicin—urinary bladder cancer	0.000711	0.000979	CcSEcCtD
Vigabatrin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00071	0.000977	CcSEcCtD
Vigabatrin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000702	0.000965	CcSEcCtD
Vigabatrin—Paraesthesia—Etoposide—urinary bladder cancer	0.0007	0.000964	CcSEcCtD
Vigabatrin—Weight increased—Epirubicin—urinary bladder cancer	0.0007	0.000963	CcSEcCtD
Vigabatrin—Somnolence—Etoposide—urinary bladder cancer	0.000693	0.000954	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000693	0.000953	CcSEcCtD
Vigabatrin—Vomiting—Thiotepa—urinary bladder cancer	0.00069	0.00095	CcSEcCtD
Vigabatrin—Pneumonia—Epirubicin—urinary bladder cancer	0.00069	0.000949	CcSEcCtD
Vigabatrin—Infestation NOS—Epirubicin—urinary bladder cancer	0.000686	0.000943	CcSEcCtD
Vigabatrin—Drowsiness—Epirubicin—urinary bladder cancer	0.000686	0.000943	CcSEcCtD
Vigabatrin—Infestation—Epirubicin—urinary bladder cancer	0.000686	0.000943	CcSEcCtD
Vigabatrin—Rash—Thiotepa—urinary bladder cancer	0.000685	0.000942	CcSEcCtD
Vigabatrin—Bronchitis—Doxorubicin—urinary bladder cancer	0.000684	0.000941	CcSEcCtD
Vigabatrin—Dermatitis—Thiotepa—urinary bladder cancer	0.000684	0.000941	CcSEcCtD
Vigabatrin—Headache—Thiotepa—urinary bladder cancer	0.00068	0.000936	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00068	0.000935	CcSEcCtD
Vigabatrin—Decreased appetite—Etoposide—urinary bladder cancer	0.000678	0.000933	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000673	0.000926	CcSEcCtD
Vigabatrin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000673	0.000926	CcSEcCtD
Vigabatrin—Fatigue—Etoposide—urinary bladder cancer	0.000672	0.000925	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000672	0.000924	CcSEcCtD
Vigabatrin—Pain—Etoposide—urinary bladder cancer	0.000667	0.000918	CcSEcCtD
Vigabatrin—Constipation—Etoposide—urinary bladder cancer	0.000667	0.000918	CcSEcCtD
Vigabatrin—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000666	0.000917	CcSEcCtD
Vigabatrin—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000666	0.000917	CcSEcCtD
Vigabatrin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000662	0.00091	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000661	0.00091	CcSEcCtD
Vigabatrin—Asthenia—Gemcitabine—urinary bladder cancer	0.000655	0.000902	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000648	0.000892	CcSEcCtD
Vigabatrin—Weight increased—Doxorubicin—urinary bladder cancer	0.000647	0.000891	CcSEcCtD
Vigabatrin—Pruritus—Gemcitabine—urinary bladder cancer	0.000646	0.000889	CcSEcCtD
Vigabatrin—Nausea—Thiotepa—urinary bladder cancer	0.000645	0.000887	CcSEcCtD
Vigabatrin—Sinusitis—Epirubicin—urinary bladder cancer	0.000643	0.000885	CcSEcCtD
Vigabatrin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000643	0.000884	CcSEcCtD
Vigabatrin—Pneumonia—Doxorubicin—urinary bladder cancer	0.000638	0.000878	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000638	0.000877	CcSEcCtD
Vigabatrin—Pruritus—Fluorouracil—urinary bladder cancer	0.000635	0.000874	CcSEcCtD
Vigabatrin—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000634	0.000873	CcSEcCtD
Vigabatrin—Drowsiness—Doxorubicin—urinary bladder cancer	0.000634	0.000873	CcSEcCtD
Vigabatrin—Infestation—Doxorubicin—urinary bladder cancer	0.000634	0.000873	CcSEcCtD
Vigabatrin—Visual impairment—Methotrexate—urinary bladder cancer	0.000634	0.000872	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000629	0.000865	CcSEcCtD
Vigabatrin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000627	0.000863	CcSEcCtD
Vigabatrin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000625	0.00086	CcSEcCtD
Vigabatrin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000622	0.000855	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000622	0.000855	CcSEcCtD
Vigabatrin—Urticaria—Etoposide—urinary bladder cancer	0.00062	0.000852	CcSEcCtD
Vigabatrin—Abdominal pain—Etoposide—urinary bladder cancer	0.000617	0.000848	CcSEcCtD
Vigabatrin—Body temperature increased—Etoposide—urinary bladder cancer	0.000617	0.000848	CcSEcCtD
Vigabatrin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000617	0.000848	CcSEcCtD
Vigabatrin—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000617	0.000848	CcSEcCtD
Vigabatrin—Eye disorder—Methotrexate—urinary bladder cancer	0.000615	0.000845	CcSEcCtD
Vigabatrin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000614	0.000845	CcSEcCtD
Vigabatrin—Tinnitus—Methotrexate—urinary bladder cancer	0.000613	0.000844	CcSEcCtD
Vigabatrin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000612	0.000842	CcSEcCtD
Vigabatrin—Asthenia—Cisplatin—urinary bladder cancer	0.000611	0.00084	CcSEcCtD
Vigabatrin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000606	0.000834	CcSEcCtD
Vigabatrin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000605	0.000832	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.0006	0.000825	CcSEcCtD
Vigabatrin—Sinusitis—Doxorubicin—urinary bladder cancer	0.000595	0.000819	CcSEcCtD
Vigabatrin—Dizziness—Fluorouracil—urinary bladder cancer	0.000594	0.000817	CcSEcCtD
Vigabatrin—Visual impairment—Epirubicin—urinary bladder cancer	0.000593	0.000816	CcSEcCtD
Vigabatrin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000583	0.000801	CcSEcCtD
Vigabatrin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000582	0.000801	CcSEcCtD
Vigabatrin—Vomiting—Gemcitabine—urinary bladder cancer	0.000581	0.000799	CcSEcCtD
Vigabatrin—Mental disorder—Methotrexate—urinary bladder cancer	0.000576	0.000793	CcSEcCtD
Vigabatrin—Rash—Gemcitabine—urinary bladder cancer	0.000576	0.000792	CcSEcCtD
Vigabatrin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000575	0.000792	CcSEcCtD
Vigabatrin—Eye disorder—Epirubicin—urinary bladder cancer	0.000575	0.000791	CcSEcCtD
Vigabatrin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000575	0.000791	CcSEcCtD
Vigabatrin—Tinnitus—Epirubicin—urinary bladder cancer	0.000574	0.000789	CcSEcCtD
Vigabatrin—Malnutrition—Methotrexate—urinary bladder cancer	0.000572	0.000788	CcSEcCtD
Vigabatrin—Headache—Gemcitabine—urinary bladder cancer	0.000572	0.000787	CcSEcCtD
Vigabatrin—Vomiting—Fluorouracil—urinary bladder cancer	0.000571	0.000786	CcSEcCtD
Vigabatrin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000567	0.000779	CcSEcCtD
Vigabatrin—Rash—Fluorouracil—urinary bladder cancer	0.000566	0.000779	CcSEcCtD
Vigabatrin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000566	0.000778	CcSEcCtD
Vigabatrin—Headache—Fluorouracil—urinary bladder cancer	0.000563	0.000774	CcSEcCtD
Vigabatrin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000561	0.000772	CcSEcCtD
Vigabatrin—Asthenia—Etoposide—urinary bladder cancer	0.00056	0.00077	CcSEcCtD
Vigabatrin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00056	0.00077	CcSEcCtD
Vigabatrin—Back pain—Methotrexate—urinary bladder cancer	0.000554	0.000762	CcSEcCtD
Vigabatrin—Pruritus—Etoposide—urinary bladder cancer	0.000552	0.000759	CcSEcCtD
Vigabatrin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000549	0.000755	CcSEcCtD
Vigabatrin—Nausea—Gemcitabine—urinary bladder cancer	0.000543	0.000746	CcSEcCtD
Vigabatrin—Vomiting—Cisplatin—urinary bladder cancer	0.000541	0.000745	CcSEcCtD
Vigabatrin—Vision blurred—Methotrexate—urinary bladder cancer	0.000539	0.000742	CcSEcCtD
Vigabatrin—Mental disorder—Epirubicin—urinary bladder cancer	0.000539	0.000742	CcSEcCtD
Vigabatrin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000538	0.000741	CcSEcCtD
Vigabatrin—Rash—Cisplatin—urinary bladder cancer	0.000537	0.000739	CcSEcCtD
Vigabatrin—Dermatitis—Cisplatin—urinary bladder cancer	0.000536	0.000738	CcSEcCtD
Vigabatrin—Malnutrition—Epirubicin—urinary bladder cancer	0.000536	0.000737	CcSEcCtD
Vigabatrin—Diarrhoea—Etoposide—urinary bladder cancer	0.000534	0.000734	CcSEcCtD
Vigabatrin—Nausea—Fluorouracil—urinary bladder cancer	0.000533	0.000734	CcSEcCtD
Vigabatrin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000532	0.000732	CcSEcCtD
Vigabatrin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000531	0.000731	CcSEcCtD
Vigabatrin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000531	0.00073	CcSEcCtD
Vigabatrin—Anaemia—Methotrexate—urinary bladder cancer	0.000529	0.000728	CcSEcCtD
Vigabatrin—Tension—Epirubicin—urinary bladder cancer	0.000526	0.000723	CcSEcCtD
Vigabatrin—Nervousness—Epirubicin—urinary bladder cancer	0.00052	0.000716	CcSEcCtD
Vigabatrin—Back pain—Epirubicin—urinary bladder cancer	0.000518	0.000713	CcSEcCtD
Vigabatrin—Malaise—Methotrexate—urinary bladder cancer	0.000516	0.00071	CcSEcCtD
Vigabatrin—Dizziness—Etoposide—urinary bladder cancer	0.000516	0.00071	CcSEcCtD
Vigabatrin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000515	0.000709	CcSEcCtD
Vigabatrin—Vertigo—Methotrexate—urinary bladder cancer	0.000514	0.000708	CcSEcCtD
Vigabatrin—Nausea—Cisplatin—urinary bladder cancer	0.000506	0.000696	CcSEcCtD
Vigabatrin—Vision blurred—Epirubicin—urinary bladder cancer	0.000505	0.000695	CcSEcCtD
Vigabatrin—Cough—Methotrexate—urinary bladder cancer	0.0005	0.000687	CcSEcCtD
Vigabatrin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000499	0.000686	CcSEcCtD
Vigabatrin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000497	0.000684	CcSEcCtD
Vigabatrin—Convulsion—Methotrexate—urinary bladder cancer	0.000496	0.000682	CcSEcCtD
Vigabatrin—Vomiting—Etoposide—urinary bladder cancer	0.000496	0.000682	CcSEcCtD
Vigabatrin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000496	0.000682	CcSEcCtD
Vigabatrin—Anaemia—Epirubicin—urinary bladder cancer	0.000495	0.000681	CcSEcCtD
Vigabatrin—Agitation—Epirubicin—urinary bladder cancer	0.000492	0.000677	CcSEcCtD
Vigabatrin—Rash—Etoposide—urinary bladder cancer	0.000492	0.000677	CcSEcCtD
Vigabatrin—Dermatitis—Etoposide—urinary bladder cancer	0.000491	0.000676	CcSEcCtD
Vigabatrin—Headache—Etoposide—urinary bladder cancer	0.000489	0.000672	CcSEcCtD
Vigabatrin—Chest pain—Methotrexate—urinary bladder cancer	0.000487	0.00067	CcSEcCtD
Vigabatrin—Myalgia—Methotrexate—urinary bladder cancer	0.000487	0.00067	CcSEcCtD
Vigabatrin—Arthralgia—Methotrexate—urinary bladder cancer	0.000487	0.00067	CcSEcCtD
Vigabatrin—Tension—Doxorubicin—urinary bladder cancer	0.000486	0.000669	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000484	0.000666	CcSEcCtD
Vigabatrin—Malaise—Epirubicin—urinary bladder cancer	0.000483	0.000665	CcSEcCtD
Vigabatrin—Discomfort—Methotrexate—urinary bladder cancer	0.000482	0.000662	CcSEcCtD
Vigabatrin—Nervousness—Doxorubicin—urinary bladder cancer	0.000481	0.000662	CcSEcCtD
Vigabatrin—Vertigo—Epirubicin—urinary bladder cancer	0.000481	0.000662	CcSEcCtD
Vigabatrin—Back pain—Doxorubicin—urinary bladder cancer	0.000479	0.00066	CcSEcCtD
Vigabatrin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000477	0.000656	CcSEcCtD
Vigabatrin—Confusional state—Methotrexate—urinary bladder cancer	0.000471	0.000648	CcSEcCtD
Vigabatrin—Cough—Epirubicin—urinary bladder cancer	0.000467	0.000643	CcSEcCtD
Vigabatrin—Vision blurred—Doxorubicin—urinary bladder cancer	0.000467	0.000643	CcSEcCtD
Vigabatrin—Convulsion—Epirubicin—urinary bladder cancer	0.000464	0.000639	CcSEcCtD
Vigabatrin—Infection—Methotrexate—urinary bladder cancer	0.000464	0.000639	CcSEcCtD
Vigabatrin—Nausea—Etoposide—urinary bladder cancer	0.000463	0.000637	CcSEcCtD
Vigabatrin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00046	0.000633	CcSEcCtD
Vigabatrin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000458	0.00063	CcSEcCtD
Vigabatrin—Anaemia—Doxorubicin—urinary bladder cancer	0.000458	0.00063	CcSEcCtD
Vigabatrin—Myalgia—Epirubicin—urinary bladder cancer	0.000456	0.000627	CcSEcCtD
Vigabatrin—Chest pain—Epirubicin—urinary bladder cancer	0.000456	0.000627	CcSEcCtD
Vigabatrin—Arthralgia—Epirubicin—urinary bladder cancer	0.000456	0.000627	CcSEcCtD
Vigabatrin—Agitation—Doxorubicin—urinary bladder cancer	0.000456	0.000627	CcSEcCtD
Vigabatrin—Anxiety—Epirubicin—urinary bladder cancer	0.000455	0.000625	CcSEcCtD
Vigabatrin—Skin disorder—Methotrexate—urinary bladder cancer	0.000454	0.000624	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000453	0.000623	CcSEcCtD
Vigabatrin—Discomfort—Epirubicin—urinary bladder cancer	0.000451	0.00062	CcSEcCtD
Vigabatrin—Malaise—Doxorubicin—urinary bladder cancer	0.000447	0.000615	CcSEcCtD
Vigabatrin—Vertigo—Doxorubicin—urinary bladder cancer	0.000445	0.000613	CcSEcCtD
Vigabatrin—Confusional state—Epirubicin—urinary bladder cancer	0.000441	0.000606	CcSEcCtD
Vigabatrin—Oedema—Epirubicin—urinary bladder cancer	0.000437	0.000602	CcSEcCtD
Vigabatrin—Infection—Epirubicin—urinary bladder cancer	0.000434	0.000598	CcSEcCtD
Vigabatrin—Cough—Doxorubicin—urinary bladder cancer	0.000433	0.000595	CcSEcCtD
Vigabatrin—Convulsion—Doxorubicin—urinary bladder cancer	0.000429	0.000591	CcSEcCtD
Vigabatrin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000429	0.00059	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000426	0.000586	CcSEcCtD
Vigabatrin—Skin disorder—Epirubicin—urinary bladder cancer	0.000425	0.000584	CcSEcCtD
Vigabatrin—Insomnia—Methotrexate—urinary bladder cancer	0.000423	0.000581	CcSEcCtD
Vigabatrin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000422	0.000581	CcSEcCtD
Vigabatrin—Myalgia—Doxorubicin—urinary bladder cancer	0.000422	0.000581	CcSEcCtD
Vigabatrin—Chest pain—Doxorubicin—urinary bladder cancer	0.000422	0.000581	CcSEcCtD
Vigabatrin—Anxiety—Doxorubicin—urinary bladder cancer	0.000421	0.000579	CcSEcCtD
Vigabatrin—Paraesthesia—Methotrexate—urinary bladder cancer	0.00042	0.000577	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000419	0.000577	CcSEcCtD
Vigabatrin—Discomfort—Doxorubicin—urinary bladder cancer	0.000417	0.000574	CcSEcCtD
Vigabatrin—Somnolence—Methotrexate—urinary bladder cancer	0.000415	0.000571	CcSEcCtD
Vigabatrin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000411	0.000566	CcSEcCtD
Vigabatrin—Confusional state—Doxorubicin—urinary bladder cancer	0.000408	0.000561	CcSEcCtD
Vigabatrin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000406	0.000559	CcSEcCtD
Vigabatrin—Oedema—Doxorubicin—urinary bladder cancer	0.000405	0.000557	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000403	0.000555	CcSEcCtD
Vigabatrin—Fatigue—Methotrexate—urinary bladder cancer	0.000403	0.000554	CcSEcCtD
Vigabatrin—Infection—Doxorubicin—urinary bladder cancer	0.000402	0.000553	CcSEcCtD
Vigabatrin—Pain—Methotrexate—urinary bladder cancer	0.0004	0.00055	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000398	0.000548	CcSEcCtD
Vigabatrin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000397	0.000546	CcSEcCtD
Vigabatrin—Insomnia—Epirubicin—urinary bladder cancer	0.000395	0.000544	CcSEcCtD
Vigabatrin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000393	0.000541	CcSEcCtD
Vigabatrin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000393	0.00054	CcSEcCtD
Vigabatrin—Somnolence—Epirubicin—urinary bladder cancer	0.000389	0.000535	CcSEcCtD
Vigabatrin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000385	0.00053	CcSEcCtD
Vigabatrin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000385	0.000529	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000382	0.000526	CcSEcCtD
Vigabatrin—Decreased appetite—Epirubicin—urinary bladder cancer	0.00038	0.000523	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000377	0.000519	CcSEcCtD
Vigabatrin—Fatigue—Epirubicin—urinary bladder cancer	0.000377	0.000519	CcSEcCtD
Vigabatrin—Pain—Epirubicin—urinary bladder cancer	0.000374	0.000514	CcSEcCtD
Vigabatrin—Constipation—Epirubicin—urinary bladder cancer	0.000374	0.000514	CcSEcCtD
Vigabatrin—Urticaria—Methotrexate—urinary bladder cancer	0.000371	0.000511	CcSEcCtD
Vigabatrin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000369	0.000508	CcSEcCtD
Vigabatrin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000369	0.000508	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000369	0.000507	CcSEcCtD
Vigabatrin—Insomnia—Doxorubicin—urinary bladder cancer	0.000366	0.000503	CcSEcCtD
Vigabatrin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000363	0.0005	CcSEcCtD
Vigabatrin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00036	0.000496	CcSEcCtD
Vigabatrin—Somnolence—Doxorubicin—urinary bladder cancer	0.00036	0.000495	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000358	0.000492	CcSEcCtD
Vigabatrin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000356	0.00049	CcSEcCtD
Vigabatrin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000352	0.000484	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000349	0.00048	CcSEcCtD
Vigabatrin—Fatigue—Doxorubicin—urinary bladder cancer	0.000349	0.00048	CcSEcCtD
Vigabatrin—Urticaria—Epirubicin—urinary bladder cancer	0.000347	0.000478	CcSEcCtD
Vigabatrin—Constipation—Doxorubicin—urinary bladder cancer	0.000346	0.000476	CcSEcCtD
Vigabatrin—Pain—Doxorubicin—urinary bladder cancer	0.000346	0.000476	CcSEcCtD
Vigabatrin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000346	0.000475	CcSEcCtD
Vigabatrin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000346	0.000475	CcSEcCtD
Vigabatrin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000344	0.000474	CcSEcCtD
Vigabatrin—Asthenia—Methotrexate—urinary bladder cancer	0.000335	0.000461	CcSEcCtD
Vigabatrin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000333	0.000459	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000331	0.000455	CcSEcCtD
Vigabatrin—Pruritus—Methotrexate—urinary bladder cancer	0.000331	0.000455	CcSEcCtD
Vigabatrin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000322	0.000443	CcSEcCtD
Vigabatrin—Urticaria—Doxorubicin—urinary bladder cancer	0.000321	0.000442	CcSEcCtD
Vigabatrin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00032	0.00044	CcSEcCtD
Vigabatrin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00032	0.00044	CcSEcCtD
Vigabatrin—Diarrhoea—Methotrexate—urinary bladder cancer	0.00032	0.00044	CcSEcCtD
Vigabatrin—Asthenia—Epirubicin—urinary bladder cancer	0.000314	0.000432	CcSEcCtD
Vigabatrin—Pruritus—Epirubicin—urinary bladder cancer	0.000309	0.000426	CcSEcCtD
Vigabatrin—Dizziness—Methotrexate—urinary bladder cancer	0.000309	0.000425	CcSEcCtD
Vigabatrin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000299	0.000412	CcSEcCtD
Vigabatrin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000298	0.00041	CcSEcCtD
Vigabatrin—Vomiting—Methotrexate—urinary bladder cancer	0.000297	0.000409	CcSEcCtD
Vigabatrin—Rash—Methotrexate—urinary bladder cancer	0.000295	0.000405	CcSEcCtD
Vigabatrin—Dermatitis—Methotrexate—urinary bladder cancer	0.000294	0.000405	CcSEcCtD
Vigabatrin—Headache—Methotrexate—urinary bladder cancer	0.000293	0.000403	CcSEcCtD
Vigabatrin—Asthenia—Doxorubicin—urinary bladder cancer	0.00029	0.000399	CcSEcCtD
Vigabatrin—Dizziness—Epirubicin—urinary bladder cancer	0.000289	0.000398	CcSEcCtD
Vigabatrin—Pruritus—Doxorubicin—urinary bladder cancer	0.000286	0.000394	CcSEcCtD
Vigabatrin—Vomiting—Epirubicin—urinary bladder cancer	0.000278	0.000382	CcSEcCtD
Vigabatrin—Nausea—Methotrexate—urinary bladder cancer	0.000278	0.000382	CcSEcCtD
Vigabatrin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000277	0.000381	CcSEcCtD
Vigabatrin—Rash—Epirubicin—urinary bladder cancer	0.000276	0.000379	CcSEcCtD
Vigabatrin—Dermatitis—Epirubicin—urinary bladder cancer	0.000275	0.000379	CcSEcCtD
Vigabatrin—Headache—Epirubicin—urinary bladder cancer	0.000274	0.000377	CcSEcCtD
Vigabatrin—Dizziness—Doxorubicin—urinary bladder cancer	0.000268	0.000368	CcSEcCtD
Vigabatrin—Nausea—Epirubicin—urinary bladder cancer	0.00026	0.000357	CcSEcCtD
Vigabatrin—Vomiting—Doxorubicin—urinary bladder cancer	0.000257	0.000354	CcSEcCtD
Vigabatrin—Rash—Doxorubicin—urinary bladder cancer	0.000255	0.000351	CcSEcCtD
Vigabatrin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000255	0.000351	CcSEcCtD
Vigabatrin—Headache—Doxorubicin—urinary bladder cancer	0.000253	0.000349	CcSEcCtD
Vigabatrin—Nausea—Doxorubicin—urinary bladder cancer	0.00024	0.000331	CcSEcCtD
